Schlagwörter
/dk/atira/pure/keywords/researchprograms/AFL000800/EMCNIHES056302
6
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038608
6
name=EMC MM-03-86-08
6
name=EMC NIHES-05-63-02 Quality
6
DABRAFENIB
4
Environmental and Occupational Health
4
Health Policy
4
Hematology
4
IMPACT
4
MULTICENTER
4
Metastatic melanoma
4
Oncology
4
Public Health
4
VEMURAFENIB
4
advanced melanoma
4
survival
4
systemic therapy
4
AGE
2
COVID-19
2
DOUBLE-BLIND
2
Dutch melanoma treatment registry
2
IMMUNOTHERAPY
2
IPILIMUMAB
2
Immune checkpoint inhibitors
2
METASTATIC MELANOMA
2
Metastatic uveal melanoma
2
NIVOLUMAB
2
Older patients
2
Outcome
2
POOLED ANALYSIS
2
Prognostic factor
2
STAGE-III
2
Safety
2
Surgery
2
Survival
2
Systemic therapy
2
Targeted therapy
2
Treatment strategy
2
Uveal melanoma
2
braf
2
center variation
2
clinical outcomes
2
combined nivolumab
2
dabrafenib
2
double-blind
2
dutch melanoma treatment registry
2
ipilimumab
2
metastatic melanoma
2
multicenter
2
nationwide registry
2
weitere ...